Bicycle Therapeutics (BCYC) Profit After Tax (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Profit After Tax data on file, last reported at -$50.5 million in Q2 2026.

• Quarterly Profit After Tax rose 37.58% year-over-year to -$50.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$190.7 million (up 22.0% YoY) and the FY2025 annual result came in at -$222.6 million, down 31.68% from the prior year.
• Profit After Tax rose to -$50.5 million in Q2 2026, from -$60.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$20.2 million in Q4 2025 to a low of -$80.9 million in Q2 2025.
• A 5-year average of -$44.3 million and a median of -$46.3 million in 2023 frame the typical range for Profit After Tax.
• The widest YoY moves for Profit After Tax: up 59.6% in 2025, down 128.72% in 2025.
• Tracing BCYC's Profit After Tax over 5 years: stood at -$30.0 million in 2022, then sank by 69.31% to -$50.8 million in 2023, then rose by 1.54% to -$50.0 million in 2024, then surged by 59.6% to -$20.2 million in 2025, then slumped by 150.0% to -$50.5 million in 2026.
• The last three Profit After Tax figures came in at -$50.5 million (Q2 2026), -$60.8 million (Q1 2026), and -$20.2 million (Q4 2025), per Business Quant data.